Published in Curr Opin Ophthalmol on August 01, 2001
Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization | NCT02797704
Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea | NCT01868360
Corneal avascularity is due to soluble VEGF receptor-1. Nature (2006) 4.77
Short-term topical bevacizumab in the treatment of stable corneal neovascularization. Am J Ophthalmol (2012) 2.14
Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2006) 2.12
Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. Arch Ophthalmol (2009) 1.60
Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity. Blood (2013) 1.56
Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin). Br J Ophthalmol (2006) 1.48
Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res (2010) 1.33
Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2007) 1.33
Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol (2012) 1.21
Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth. Proc Natl Acad Sci U S A (2011) 1.20
Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2009) 1.18
Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. Invest Ophthalmol Vis Sci (2009) 1.18
Corneal transparency: genesis, maintenance and dysfunction. Brain Res Bull (2009) 1.18
Mediators of ocular angiogenesis. J Genet (2009) 1.17
Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2007) 1.15
Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. J Exp Med (2011) 1.10
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf (2012) 1.08
Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J Immunol (2011) 1.07
Maintaining transparency: a review of the developmental physiology and pathophysiology of two avascular tissues. Semin Cell Dev Biol (2007) 1.07
Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization. Prog Retin Eye Res (2012) 1.05
Subconjunctival bevacizumab for corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2007) 0.99
Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab. J Ophthalmol (2014) 0.94
MT1-MMP-mediated cleavage of decorin in corneal angiogenesis. J Vasc Res (2009) 0.94
S100A proteins in the pathogenesis of experimental corneal neovascularization. Mol Vis (2010) 0.93
Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1. Mol Vis (2010) 0.93
Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis. Graefes Arch Clin Exp Ophthalmol (2009) 0.93
Human cornea proteome: identification and quantitation of the proteins of the three main layers including epithelium, stroma, and endothelium. J Proteome Res (2012) 0.93
Essential contribution of CCL3 to alkali-induced corneal neovascularization by regulating vascular endothelial growth factor production by macrophages. Mol Vis (2008) 0.91
Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model. Mol Pharm (2012) 0.90
Inhibitory effects of polysaccharide extract from Spirulina platensis on corneal neovascularization. Mol Vis (2009) 0.90
Pharmacologic uncoupling of angiogenesis and inflammation during initiation of pathological corneal neovascularization. J Biol Chem (2011) 0.90
Inhibition of corneal angiogenesis by ascorbic acid in the rat model. Graefes Arch Clin Exp Ophthalmol (2007) 0.90
Topical ranibizumab as a treatment of corneal neovascularization. Cornea (2013) 0.89
MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts. Protein Pept Lett (2012) 0.89
Dual suppression of hemangiogenesis and lymphangiogenesis by splice-shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR). FASEB J (2012) 0.89
Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularization. Invest Ophthalmol Vis Sci (2012) 0.88
Localization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo. Mol Vis (2010) 0.88
The effect of doxycycline temperature-sensitive hydrogel on inhibiting the corneal neovascularization induced by BFGF in rats. Graefes Arch Clin Exp Ophthalmol (2010) 0.87
Cellular and extracellular matrix modulation of corneal stromal opacity. Exp Eye Res (2014) 0.87
Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization. Mol Vis (2009) 0.86
Topically administered bevacizumab had longer standing anti-angiogenic effect than subconjunctivally injected bevacizumab in rat corneal neovacularization. Int J Ophthalmol (2013) 0.85
Polymeric vectors for ocular gene delivery. Ther Deliv (2011) 0.84
An alkali-burn injury model of corneal neovascularization in the mouse. J Vis Exp (2014) 0.84
Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications. Biochim Biophys Acta (2015) 0.84
Hemangiogenesis and lymphangiogenesis in corneal pathology. Cornea (2012) 0.84
Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy. Br J Pharmacol (2013) 0.83
Comparison of the effects of bevacizumab and ranibizumab injection on corneal angiogenesis in an alkali burn induced model. Int J Ophthalmol (2012) 0.83
Emerging techniques to treat corneal neovascularisation. Eye (Lond) (2011) 0.82
The effect of bevacizumab on corneal neovascularization in rabbits. Korean J Ophthalmol (2010) 0.81
The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model. Clinics (Sao Paulo) (2011) 0.81
Wound healing fibroblasts modulate corneal angiogenic privilege: interplay of basic fibroblast growth factor and matrix metalloproteinases in corneal angiogenesis. Jpn J Ophthalmol (2010) 0.81
One-year follow-up of epithelial corneal cell sheet allografts mounted on platelet poor plasma in rabbits. Mol Vis (2009) 0.81
Corneal lymphangiogenesis in herpetic stromal keratitis. Surv Ophthalmol (2014) 0.81
Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries. Toxicol Appl Pharmacol (2012) 0.81
Evaluation of pharmacological activities and assessment of intraocular penetration of an ayurvedic polyherbal eye drop (Itone™) in experimental models. BMC Complement Altern Med (2013) 0.81
Anti-neovascular effect of chondrocyte-derived extracellular matrix on corneal alkaline burns in rabbits. Graefes Arch Clin Exp Ophthalmol (2014) 0.80
KH906, a recombinant human VEGF receptor fusion protein, is a new effective topical treatment for corneal neovascularization. Mol Vis (2011) 0.80
The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization. Int Ophthalmol (2013) 0.80
Comparison of the therapeutic effects of extracts from Spirulina platensis and amnion membrane on inflammation-associated corneal neovascularization. Int J Ophthalmol (2012) 0.80
Preliminary studies of the effects of vascular adhesion protein-1 inhibitors on experimental corneal neovascularization. J Neural Transm (Vienna) (2011) 0.80
Nanotechnology in corneal neovascularization therapy--a review. J Ocul Pharmacol Ther (2013) 0.79
Corneal neovascularization during experimental fungal keratitis. Mol Vis (2009) 0.79
The effect of bevacizumab versus ranibizumab in the treatment of corneal neovascularization: a preliminary study. Korean J Ophthalmol (2013) 0.79
Femtosecond laser-assisted selective reduction of neovascularization in rat cornea. Lasers Med Sci (2014) 0.79
Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis. PLoS One (2015) 0.79
Inhibition of Ultraviolet B-Induced Expression of the Proinflammatory Cytokines TNF-α and VEGF in the Cornea by Fucoxanthin Treatment in a Rat Model. Mar Drugs (2016) 0.79
Inhibitory effects of topical cyclosporine A 0.05% on immune-mediated corneal neovascularization in rabbits. Graefes Arch Clin Exp Ophthalmol (2013) 0.79
Diospyros kaki Extract Inhibits Alkali Burn-Induced Corneal Neovascularization. J Med Food (2015) 0.79
Deletion of the FHL2 gene attenuating neovascularization after corneal injury. Invest Ophthalmol Vis Sci (2008) 0.79
Corneal Cross-Linking with Riboflavin and UV-A in the Mouse Cornea in Vivo: Morphological, Biochemical, and Physiological Analysis. Transl Vis Sci Technol (2017) 0.79
Topical dihydroartemisinin inhibits suture-induced neovascularization in rat corneas through ERK1/2 and p38 pathways. Int J Ophthalmol (2011) 0.78
Therapeutic effects of topical netrin-4 inhibits corneal neovascularization in alkali-burn rats. PLoS One (2015) 0.78
Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization. Invest Ophthalmol Vis Sci (2013) 0.78
Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization. PLoS One (2014) 0.78
Ranibizumab injection for corneal neovascularization refractory to bevacizumab treatment. Korean J Ophthalmol (2014) 0.78
Prevention of exuberant granulation tissue and neovascularization in the rat cornea by naltrexone. Arch Ophthalmol (2008) 0.78
Sodium hyaluronate eye drops treatment for superficial corneal abrasion caused by mechanical damage: a randomized clinical trial in the People's Republic of China. Drug Des Devel Ther (2015) 0.77
Corneal neovascularization and biological therapy. J Med Life (2015) 0.77
Glucocorticoid action in human corneal epithelial cells establishes roles for corticosteroids in wound healing and barrier function of the eye. Exp Eye Res (2016) 0.77
Simultaneous in vivo imaging of blood and lymphatic vessel growth in Prox1-GFP/Flk1::myr-mCherry mice. FEBS J (2015) 0.77
Transplantation of PEDF-transfected pigment epithelial cells inhibits corneal neovascularization in a rabbit model. Graefes Arch Clin Exp Ophthalmol (2015) 0.77
Effects of estrogen replacement therapy on apoptosis and vascular endothelial growth factor expression in ocular surface epithelial cells: An experimental study. Int J Ophthalmol (2012) 0.77
Paxillin regulates vascular endothelial growth factor A-induced in vitro angiogenesis of human umbilical vein endothelial cells. Mol Med Rep (2014) 0.77
Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model. Int J Ophthalmol (2013) 0.77
Ultrastructural pathology of corneal neovascularization after photodynamic therapy in rabbits. Int J Ophthalmol (2010) 0.77
The potential utilizations of hydrogen as a promising therapeutic strategy against ocular diseases. Ther Clin Risk Manag (2016) 0.76
Glycobiology of ocular angiogenesis. Glycobiology (2014) 0.76
Inhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model. Int J Mol Sci (2013) 0.76
Comparison of the antiangiogenic activity of modified RGDRGD-endostatin to endostatin delivered by gene transfer in vivo rabbit neovascularization model. Mol Vis (2011) 0.76
Prophylactic effect of topical silica nanoparticles as a novel antineovascularization agent for inhibiting corneal neovascularization following chemical burn. Adv Biomed Res (2015) 0.76
Graft failure: II. Ocular surface complications. Int Ophthalmol (2008) 0.76
Inhibitory effects of (90)Sr/(90)Y β-irradiation on alkali burn-induced corneal neovascularization in rats. Exp Ther Med (2015) 0.76
[Limbal stem cell deficiency after chemical burns : investigations on the epithelial phenotype and inflammation status]. Ophthalmologe (2009) 0.76
Three-year corneal graft survival rate in high-risk cases treated with subconjunctival and topical bevacizumab. Graefes Arch Clin Exp Ophthalmol (2014) 0.76
Infliximab eye drops treatment in corneal neovascularization. J Med Life (2015) 0.75
Eyes wide s-flt: clearly, avascular fidelity is a vascular endothelial growth factor family affair. Br J Ophthalmol (2007) 0.75
Chemical injury treated with autologous limbal epithelial stem cell transplantation and subconjunctival bevacizumab. Clin Ophthalmol (2014) 0.75
Inhibition of corneal neovascularization by topical and subconjunctival tigecycline. J Ophthalmol (2014) 0.75
Screening of antiangiogenic potential of twenty two marine invertebrate extracts of phylum Mollusca from South East Coast of India. Asian Pac J Trop Biomed (2014) 0.75
Fasudil hydrochloride, a potent ROCK inhibitor, inhibits corneal neovascularization after alkali burns in mice. Mol Vis (2015) 0.75
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
In vitro hemolytic characteristic of Vibrio parahaemolyticus: its close correlation with human pathogenicity. J Bacteriol (1969) 8.04
The rate of loss of weight in skeletal muscle after nerve section with some observations on the effect of stimulation and other treatment. J Physiol (1915) 6.49
Laser in situ keratomileusis versus photorefractive keratectomy: an update on indications and safety. Ophthalmology (1998) 6.44
Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat Cell Biol (1999) 5.84
Isolation and characterization of mutants of Escherichia coli deficient in induction of mutations by ultraviolet light. Mol Gen Genet (1977) 5.61
Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs (1996) 5.45
Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care (1999) 5.37
Studies on the enteropathogenic, facultatively halophilic bacterium, Vibrio parahaemolyticus. 3. Enteropathogenicity. Jpn J Med Sci Biol (1968) 5.35
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet (2000) 5.26
Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res (2000) 4.94
Identification of CRE1 as a cytokinin receptor from Arabidopsis. Nature (2001) 4.77
The physiological action of physostigmine and its action on denervated skeletal muscle. J Physiol (1915) 4.37
RecA protein-dependent cleavage of UmuD protein and SOS mutagenesis. Proc Natl Acad Sci U S A (1988) 4.12
A novel method for phosphorylation of nucleosides to 5'-nucleotides. Tetrahedron Lett (1967) 4.11
Arabidopsis NPL1: a phototropin homolog controlling the chloroplast high-light avoidance response. Science (2001) 3.93
Regulation of drought tolerance by gene manipulation of 9-cis-epoxycarotenoid dioxygenase, a key enzyme in abscisic acid biosynthesis in Arabidopsis. Plant J (2001) 3.92
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage (2002) 3.88
Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res (2001) 3.18
Determination of the ID50 values of antibacterial agents in agar. J Antibiot (Tokyo) (1978) 3.08
Base-change mutagenesis and prophage induction in strains of Escherichia coli with different DNA repair capacities. Genetics (1970) 3.05
Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol (1997) 2.89
Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 2.62
Hyperammonaemia and Helicobacter pylori. Lancet (1995) 2.59
ARR1, a transcription factor for genes immediately responsive to cytokinins. Science (2001) 2.50
Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function? Gut (2001) 2.49
Genetic evidence that the endodermis is essential for shoot gravitropism in Arabidopsis thaliana. Plant J (1998) 2.41
Spectrodensitometric determination of trichothecene mycotoxins with 4-(p-nitrobenzyl)pyridine on silica gel thin-layer chromatograms. J Chromatogr (1979) 2.38
Genetic and molecular characteristics of X-ray-sensitive mutants of Escherichia coli defective in repair synthesis. J Bacteriol (1970) 2.37
The human amygdala plays an important role in gaze monitoring. A PET study. Brain (1999) 2.33
Norfloxacin resistance in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother (1987) 2.33
Structural analysis of the umu operon required for inducible mutagenesis in Escherichia coli. Proc Natl Acad Sci U S A (1985) 2.30
Coordination of microtubules and the actin cytoskeleton by the Rho effector mDia1. Nat Cell Biol (2001) 2.27
An enzymatic cycling method for nicotinamide-adenine dinucleotide with malic and alcohol dehydrogenases. Anal Biochem (1973) 2.22
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Suppression of the heterotrimeric G protein causes abnormal morphology, including dwarfism, in rice. Proc Natl Acad Sci U S A (1999) 2.15
Subtractive cDNA cloning using oligo(dT)30-latex and PCR: isolation of cDNA clones specific to undifferentiated human embryonal carcinoma cells. Nucleic Acids Res (1991) 2.08
The endodermis and shoot gravitropism Trends Plant Sci (1999) 1.98
Role of the putative membrane-bound endo-1,4-beta-glucanase KORRIGAN in cell elongation and cellulose synthesis in Arabidopsis thaliana. Plant Cell Physiol (2001) 1.97
Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion (2001) 1.97
Cloning and characterization of the umu operon responsible for inducible mutagenesis in Escherichia coli. Gene (1983) 1.96
The resurgence of Shamonda virus, an African Simbu group virus of the genus Orthobunyavirus, in Japan. Arch Virol (2004) 1.96
Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry (2004) 1.95
Survival benefit of high ligation of the inferior mesenteric artery in sigmoid colon or rectal cancer surgery. Br J Surg (2006) 1.95
The AHK4 gene involved in the cytokinin-signaling pathway as a direct receptor molecule in Arabidopsis thaliana. Plant Cell Physiol (2001) 1.94
Overexpression of an Arabidopsis thaliana high-affinity phosphate transporter gene in tobacco cultured cells enhances cell growth under phosphate-limited conditions. Proc Natl Acad Sci U S A (1997) 1.91
Simplified purification and biophysicochemical characteristics of Kanagawa phenomenon-associated hemolysin of Vibrio parahaemolyticus. Infect Immun (1980) 1.86
Serological and pyocine types of Pseudomonas aeruginosa from various sources. Jpn J Microbiol (1968) 1.83
BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood (1995) 1.79
Mutation enhancement by DINB1, a mammalian homologue of the Escherichia coli mutagenesis protein dinB. Genes Cells (1999) 1.79
Rapid disease progression correlates with instability of mutant SOD1 in familial ALS. Neurology (2005) 1.78
Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcinogens. Mutat Res (1985) 1.76
Analysis of the role of recombination and repair in mutagenesis of Escherichia coli by UV irradiation. Genetics (1977) 1.74
Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Mol Psychiatry (2007) 1.74
Construction of a genetic linkage map of the model legume Lotus japonicus using an intraspecific F2 population. DNA Res (2001) 1.72
A simple and sensitive assay for dopamine-beta-hydroxylase activity by dual-wavelength spectrophotometry. Biochem Med (1974) 1.72
Evaluation of the pharyngeal airway in patients with sleep apnea: value of ultrafast MR imaging. AJR Am J Roentgenol (1993) 1.71
Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer (1994) 1.68
Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol (1996) 1.67
Characteristics and surgical outcomes of paediatric retinal detachment. Eye (Lond) (2004) 1.66
Gastric leptin and Helicobacter pylori infection. Gut (2001) 1.63
Laser in situ keratomileusis: literature review of a developing technique. J Cataract Refract Surg (1998) 1.61
Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer (1990) 1.61
Female preponderance of Parkinson's disease in Japan. Neuroepidemiology (2002) 1.60
Topical MMC for subepithelial fibrosis after refractive corneal surgery. Ophthalmology (2001) 1.60
Clinical and neuroradiological features of intracranial vertebrobasilar artery dissection. Stroke (1999) 1.59
Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry (2003) 1.56
Conversion of blood androgens to estrogens in normal adult men and women. J Clin Invest (1969) 1.56
Structural analysis of a Lotus japonicus genome. I. Sequence features and mapping of fifty-six TAC clones which cover the 5.4 mb regions of the genome. DNA Res (2001) 1.56
Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens. J Exp Med (1986) 1.55
The effectiveness of lymphangiography as a treatment method for various chyle leakages. Br J Radiol (2008) 1.55
C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry (1998) 1.54
Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension (1995) 1.53
Cytoplasmic and nuclear polyglutamine aggregates in SCA6 Purkinje cells. Neurology (2001) 1.53
Functional delineation of the human occipito-temporal areas related to face and scene processing. A PET study. Brain (2000) 1.52
Orthopedic symptoms in pustular bacterid (pustulosis palmaris et plantaris): Tietze's syndrome and arthritis of manubriosternal joint due to focal infection. J Dermatol (1977) 1.51
Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis. Thromb Haemost (1996) 1.51
Rho-dependent transfer of Citron-kinase to the cleavage furrow of dividing cells. J Cell Sci (2001) 1.50
Objective measurement of corneal light scattering after excimer laser keratectomy. Ophthalmology (1996) 1.50
Excision repair characteristics of recB - res - and uvrC - strains of Escherichia coli. J Bacteriol (1972) 1.50
Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol (1999) 1.49
Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology (1993) 1.48
Bruxism defined and graded: an international consensus. J Oral Rehabil (2012) 1.47
Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem (2000) 1.46
The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection. Br J Dermatol (2012) 1.45
Long-term patency of an aorta-aortic graft bypass in a patient with Takayasu arteritis. Intern Med (1998) 1.45
Salivary bisphenol-A levels detected by ELISA after restoration with composite resin. J Mater Sci Mater Med (2005) 1.45
Comparison between observation policy and fractionated stereotactic radiotherapy (SRT) as an initial management for vestibular schwannoma. Int J Radiat Oncol Biol Phys (1999) 1.44
Inguinal lymphadenopathy due to metal release from a prosthesis. A case report. J Bone Joint Surg Br (1993) 1.44
Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett (2001) 1.44
Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci Lett (1994) 1.43
Neurobiological mechanisms involved in sleep bruxism. Crit Rev Oral Biol Med (2003) 1.43
Determination of timing of brain injury in preterm infants with periventricular leukomalacia with serial neonatal electroencephalography. Pediatrics (1999) 1.43
Surgical treatment of Borrmann type IV gastric carcinoma: relevance of lymphadenectomy in improving survival. J Am Coll Surg (1996) 1.43
Involvement of rho in GTP gamma S-induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activity. FEBS Lett (1995) 1.42
Quantitative assessment of regional myocardial blood flow using oxygen-15-labelled water and positron emission tomography: a multicentre evaluation in Japan. Eur J Nucl Med (2000) 1.42